Tumor necrosis factor-related apoptosis-inducing ligand enhances collagen production by human lung fibroblasts (Q40675663)

22 September 2017

title

Tumor necrosis factor-related apoptosis-inducing ligand enhances collagen production by human lung fibroblasts (English)

1 reference

22 September 2017

Vladimir V Yurovsky

1 reference

22 September 2017

publication date

1 February 2003

1 reference

American Journal of Respiratory Cell and Molecular Biology

22 September 2017

published in

1 reference

22 September 2017

1 reference

22 September 2017

1 reference

22 September 2017

page(s)

225-231

1 reference

Identification and characterization of a new member of the TNF family that induces apoptosis

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0140OC

Surface expression of TRAIL/Apo-2 ligand in activated mouse T and B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0140OC

Development, characterization and use of monoclonal antibodies against sTRAIL: measurement of sTRAIL by ELISA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0140OC

Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0140OC

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0140OC

Mechanisms of resistance of normal cells to TRAIL induced apoptosis vary between different cell types

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0140OC

Tumor necrosis factor-related apoptosis-inducing ligand receptors signal NF-kappaB and JNK activation and apoptosis through distinct pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0140OC

The death domain kinase RIP is essential for TRAIL (Apo2L)-induced activation of IkappaB kinase and c-Jun N-terminal kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0140OC

Death Receptor 5, a New Member of the TNFR Family, and DR4 Induce FADD-Dependent Apoptosis and Activate the NF-κB Pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0140OC

TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0140OC

TRAIL/Apo2L activates c-Jun NH2-terminal kinase (JNK) via caspase-dependent and caspase-independent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0140OC

Fas signal transduction triggers either proliferation or apoptosis in human fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0140OC

Significance analysis of microarrays applied to the ionizing radiation response

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0140OC

Cluster analysis and display of genome-wide expression patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0140OC

Sp3 is a transcriptional activator of the human alpha2(I) collagen gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0140OC

An AP-1 binding sequence is essential for regulation of the human alpha2(I) collagen (COL1A2) promoter activity by transforming growth factor-beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0140OC

Latent transforming growth factor-beta 1 associates to fibroblast extracellular matrix via latent TGF-beta binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0140OC

TGF-beta signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0140OC

Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0140OC

Evidence of fibroblast heterogeneity and the role of fibroblast subpopulations in fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0140OC

AP-1 function and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0140OC

Requirements for transforming growth factor-beta regulation of the pro-alpha 2(I) collagen and plasminogen activator inhibitor-1 promoters

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0140OC

Safety and antitumor activity of recombinant soluble Apo2 ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0140OC

TGF-beta induces the expression of the FLICE-inhibitory protein and inhibits Fas-mediated apoptosis of microglia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0140OC

The short splice form of Casper/c-FLIP is a major cellular inhibitor of TRAIL-induced apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0140OC

Molecular cross-talk between the TRAIL and interferon signaling pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0140OC

Human brain-cell death induced by tumour-necrosis-factor-related apoptosis-inducing ligand (TRAIL)

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0140OC

Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0140OC

Production of type 2 cytokines by CD8+ lung cells is associated with greater decline in pulmonary function in patients with systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0140OC

Fas antigen signals proliferation of normal human diploid fibroblast and its mechanism is different from tumor necrosis factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0140OC

21 January 2018

Identifiers

DOI

10.1165/RCMB.2002-0140OC

1 reference

22 September 2017

1 reference